Brief: Reponex Obtains Patent Protection In Japan For Treatment Of Colorectal Cancer

Pharma Equity A/S

23/10/2024 09:47

Oct 23 (Reuters) - Pharma Equity Group A/S  PEGRP.CO :
    * REG-PHARMA EQUITY GROUP'S SUBSIDIARY (REPONEX
PHARMACEUTICALS
A/S) HAS OBTAINED PATENT PROTECTION IN JAPAN FOR THE TREATMENT
OF COLORECTAL CANCER WITH RNX-051.
    * PATENT VALID UNTIL 2039

Source text for Eikon:  ID:nGNEbs9WZ5 
Further company coverage:  PEGRP.CO 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))